![Levofloxacin USP RC C ; Levofloxacin USP Related Compound C ; Levofloxacin Ethyl Ester ; Ethyl (S)-9-fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylate | 177472-30-9](https://drjcrbio.com/wp-content/uploads/Levofloxacin-USP-RC-C-Levofloxacin-USP-Related-Compound-C-Levofloxacin-Ethyl-Ester-Ethyl-S-9-fluoro-23-dihydro-3-methyl-10-4-methyl-1-piperazinyl-7-oxo-7H-pyrido123-de-14-benzoxazine-6-carboxylate-177472-30-9.png)
Levofloxacin USP RC C ; Levofloxacin USP Related Compound C ; Levofloxacin Ethyl Ester ; Ethyl (S)-9-fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylate | 177472-30-9
Description
| Code: JCLEV-10 |
| CAS: 177472-30-9 |
| Chemical Formula: C20H24FN3O4 |
| Molecular Weight: 389.42 |
| Category: Reference Standards/API Drug Metabolites/EP Impurities/USP Impurities |
| Literature: |
| Application: Levofloxacin USP RC C ; Levofloxacin USP Related Compound C ; Levofloxacin Ethyl Ester ; Ethyl (S)-9-fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylate | 177472-30-9 is useful as reference Impurity standard. |
